Hanaki H - Search Results

1

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Hiramatsu K, et al. Among authors: hanaki h. J Antimicrob Chemother. 1997 Jul;40(1):135-6. doi: 10.1093/jac/40.1.135. J Antimicrob Chemother. 1997. PMID: 9249217 No abstract available.

2

Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus.

Hanaki H, Akagi H, Yasui M, Otani T. Hanaki H, et al. J Antibiot (Tokyo). 1995 Aug;48(8):901-3. doi: 10.7164/antibiotics.48.901. J Antibiot (Tokyo). 1995. PMID: 7592041 No abstract available.

3

TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.

Hanaki H, Akagi H, Masaru Y, Otani T, Hyodo A, Hiramatsu K. Hanaki H, et al. Antimicrob Agents Chemother. 1995 May;39(5):1120-6. doi: 10.1128/aac.39.5.1120. Antimicrob Agents Chemother. 1995. PMID: 7625799 Free PMC article.

4

Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.

Hanaki H, Akagi H, Nomura S, Unemi N, Hiramatsu K. Hanaki H, et al. J Antibiot (Tokyo). 1996 Apr;49(4):402-4. doi: 10.7164/antibiotics.49.402. J Antibiot (Tokyo). 1996. PMID: 8642007 No abstract available.

5

In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.

Nomura S, Hanaki H, Unemi N. Nomura S, et al. Among authors: hanaki h. Chemotherapy. 1996 Jul-Aug;42(4):253-8. doi: 10.1159/000239452. Chemotherapy. 1996. PMID: 8804792

6

In vitro and in vivo antibacterial activities of TOC-50, a new parenteral cephalosporin, against Enterococcus faecalis.

Nomura S, Hanaki H, Furukawa T, Unemi N. Nomura S, et al. Among authors: hanaki h. Chemotherapy. 1996 Nov-Dec;42(6):432-8. doi: 10.1159/000239476. Chemotherapy. 1996. PMID: 8957577

7

Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.

Nomura S, Hanaki H, Furukawa T, Unemi N. Nomura S, et al. Among authors: hanaki h. Chemotherapy. 1997 Jan-Feb;43(1):1-5. doi: 10.1159/000239527. Chemotherapy. 1997. PMID: 8996734

8

[Evaluation of reduced vancomycin susceptibility of MRSA strain Mu50 with various conditions of antibiotic susceptibility tests].

Hanaki H, Hiramatsu K. Hanaki H, et al. Jpn J Antibiot. 1997 Sep;50(9):794-8. Jpn J Antibiot. 1997. PMID: 9394239 Japanese.

9

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I. Hiramatsu K, et al. Among authors: hanaki h. Lancet. 1997 Dec 6;350(9092):1670-3. doi: 10.1016/S0140-6736(97)07324-8. Lancet. 1997. PMID: 9400512

10

[Emerging infectious and drug-resistant diseases--vancomycin resistant gram-positive cocci].

Hanaki H, Hiramatsu K. Hanaki H, et al. Nihon Naika Gakkai Zasshi. 1997 Nov 10;86(11):2075-80. Nihon Naika Gakkai Zasshi. 1997. PMID: 9480313 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results